{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rocky Mount",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77533",
      "recalling_firm": "Hospira a Pfizer Company",
      "address_1": "4285 N Wesleyan Blvd",
      "address_2": "N/A",
      "postal_code": "27804-8612",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore",
      "recall_number": "D-1046-2017",
      "product_description": "Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15 mL, Single-dose, Caution: Must Be Diluted, Rx Only, Mfd by Hospira, Inc. Lake Forest, IL 60045 USA, NDC: 0409-7295-01",
      "product_quantity": "20,337,650 15 mL single dose vials",
      "reason_for_recall": "Lack of Sterility Assurance",
      "recall_initiation_date": "20170615",
      "center_classification_date": "20170801",
      "termination_date": "20200720",
      "report_date": "20170809",
      "code_info": "Lot: 74119EV Exp. 02/01/2019  Lot: 74120EV Exp. 02/01/2019  Lot: 74121EV Exp. 02/01/2019  Lot: 74307EV Exp. 02/01/2019  Lot: 75326EV Exp. 03/01/2019  Lot: 75327EV Exp. 03/01/2019  Lot: 75215EV Exp. 03/01/2019"
    }
  ]
}